Login / Signup

Directly compressible formulation of immediate release rosuvastatin calcium tablets stabilized with tribasic calcium phosphate.

Daniel ZakowieckiTobias HessKrzysztof CalBarbara MikolaszekGrzegorz GarbaczDorota Haznar-Garbacz
Published in: Pharmaceutical development and technology (2022)
Reliable and stable tablet formulations for rosuvastatin calcium (RSC) in four strengths: 5 mg, 10 mg, 20 mg, and 40 mg have been developed. Rosuvastatin is a cholesterol-lowering statin drug and is known to be unstable during storage. The possibility of its stabilization with inorganic salts of multivalent metals has already been reported in the literature. In the present study, a special grade of tribasic calcium phosphate excipient was used to chemically stabilize RSC in a directly compressible immediate release tablet formulation. The developed tablets exhibited good mechanical properties (breaking force ranging from 177 N to 250 N depending on tablet strength), rapid disintegration (less than three minutes) and fast dissolution rate (85% of the drug substance dissolved within 15 minutes) as well as satisfactory chemical stability during storage under stress conditions (50 °C/80% RH), even compared to the reference commercial product.
Keyphrases
  • drug delivery
  • systematic review
  • cardiovascular disease
  • low density lipoprotein
  • single molecule
  • type diabetes
  • ionic liquid
  • drug induced
  • adverse drug
  • organic matter